Antitrust

10x Genomics and Harvard Overcome Patent and Antitrust Hurdles After Settling with Vizgen Inc. View More…

Artificial Intelligence

Genesis Mission and New Guidance for AI-Assisted Inventions  Impact of the Leadership in Critical Technologies Act on U.S. Artificial Intelligence, Semiconductors and Quantum Computing View More…

Biopharmaceuticals

Supreme Court Takes Up Hikma v. Amarin: Induced Infringement and Skinny Labels in the CrosshairsNovo Nordisk v. Mylan: Method of Treatment Claims Must Be Aligned with Label View More…

Biosimilars

Federal Circuit Clarifies Reach of “Artificial” Act of Patent InfringementThe Supreme Court Kept the Door Open to Genus Claims View More…

Biotechnology

The Supreme Court Kept the Door Open to Genus ClaimsUpdate on Artificial Intelligence: USPTO Urges Federal Circuit to Affirm Decision That AI Cannot Qualify as an “Inventor” View More…

Commercial Litigation

The Broad Impact of Edwards v. Meril on the Safe Harbor ProvisionPTAB Has Authority to Issue Decisions After Statutory Deadline View More…

Diagnostics

In the Orphan Drug Approval Race, Winner Takes All? Ramifications of Catalyst Pharms. v. BecerraSynthetic Data Gets Real View More…

Federal Circuit

Updates on APEX-related Personal Jurisdiction Considerations Since SnapRaysFederal Circuit Eases Expert Admissibility Threshold View More…

Generics

Federal Circuit Clarifies Reach of “Artificial” Act of Patent Infringement“Negative” Patent Claim Limitations—May They be Adequately Described by Omission? View More…

Intellectual Property

Supreme Court Reverses Federal Circuit in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: A Unanimous Decision for “Skinny Labels” and Generic Drug CompetitionSupreme Court Hears Oral Argument in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: Induced Infringement and “Skinny Labels” at a Crossroads View More…

Inter Partes Review

Federal Circuit Clarifies Limits of Issue Preclusion Between IPRs and District CourtsPTO Defends its Recent Policy Changes Regarding Discretionary Denials View More…

IP Due Diligence

The Crucial Role of Patent Due Diligence in Mergers & Acquisitions: Spotting Patent Litigation Risks Before Closing a Deal View More…

IP Protection

A New Dawn for Patent Owners? Breaking Down the PERA and PREVAIL Acts of 2025 View More…

Life Sciences

Novo Nordisk v. Mylan: Method of Treatment Claims Must Be Aligned with LabelLitigating Patents in the ITC: When and Why Companies Take the Section 337 Route View More…

Medical Devices

U.S. Medical Device Manufacturers Should Take Note of New European Medical Device RegulationsPrior Art Showing An Invention To Be “At Least Possible” Found Sufficient To Invalidate Surgical Device Patent View More…

Patent Infringement

Supreme Court Reverses Federal Circuit in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: A Unanimous Decision for “Skinny Labels” and Generic Drug CompetitionSupreme Court Hears Oral Argument in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: Induced Infringement and “Skinny Labels” at a Crossroads View More…

Patent Law

Federal Circuit Eases Expert Admissibility ThresholdSupreme Court Takes Up Hikma v. Amarin: Induced Infringement and Skinny Labels in the Crosshairs View More…

Patent Litigation

Supreme Court Takes Up Hikma v. Amarin: Induced Infringement and Skinny Labels in the CrosshairsStay Aware: Remote Employees Impact Venue Options In Patent Litigation View More…

Patents

Supreme Court Hears Oral Argument in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: Induced Infringement and “Skinny Labels” at a CrossroadsSonos, Inc. v. Google LLC: CAFC Leaves Expanded Role for Prosecution Laches in Limbo View More…

Privacy & Cybersecurity

U.S. Medical Device Manufacturers Should Take Note of New European Medical Device RegulationsSynthetic Data Gets Real View More…

PTAB

Federal Circuit Clarifies Limits of Issue Preclusion Between IPRs and District CourtsDiscretionary Denials in Action: iRhythm Technologies Inc. v. Welch Allyn Inc. View More…

Regulatory

Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 JurisprudencePTO Creates New Expectations Regarding Discretionary Denials View More…

Technology

Genesis Mission and New Guidance for AI-Assisted Inventions  Sonos, Inc. v. Google LLC: CAFC Leaves Expanded Role for Prosecution Laches in Limbo View More…

Therapeutics

Novo Nordisk v. Mylan: Method of Treatment Claims Must Be Aligned with LabelAlleged Theft of Drug Pricing Trade Secrets Could Cost Both Victim and Thief View More…

Uncategorized

Back to District Court? PTAB Strategic Recalibration in Patent LitigationPatent Litigation and the Rise of Quantum Computing: What to Watch for in the Next Decade View More…